NCT06718517View on ClinicalTrials.gov

Impact of a TDM-guided ECPA Program for Optimizing Pharmacodynamic Target Attainment of Continuous Infusion Beta-lactam-based Regimen

RecruitingOBSERVATIONAL

Enrollment

65

Participants

Timeline

Start Date

August 28, 2024

Primary Completion Date

June 30, 2026

Study Completion Date

December 31, 2026

Conditions

Liver Transplant Infection

Trial Locations (1)

40138

RECRUITING

IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna

All Listed Sponsors

lead

IRCCS Azienda Ospedaliero-Universitaria di Bologna

OTHER